DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $19.60 Consensus Target Price from Brokerages

Key Points

• DENTSPLY SIRONA has received a consensus rating of "Hold" from twelve research firms, with ten analysts recommending hold and two recommending a buy, setting an average price target of $19.60.
• The company reported a 0.43 EPS for the last quarter, exceeding estimates, but experienced a 7.8% decline in revenue year-over-year.
• DENTSPLY SIRONA recently announced a quarterly dividend of $0.16 per share, representing an annual yield of 3.98% and a payout ratio of -14.10%.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have been assigned an average recommendation of "Hold" from the twelve analysts that are currently covering the stock, MarketBeat reports. Ten research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $19.60.

Several analysts have commented on XRAY shares. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Piper Sandler lowered their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Treasurer of the State of North Carolina lifted its holdings in DENTSPLY SIRONA by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after buying an additional 560 shares in the last quarter. Quarry LP lifted its holdings in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after buying an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio lifted its holdings in DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier's stock worth $983,000 after buying an additional 861 shares in the last quarter. Federated Hermes Inc. lifted its holdings in DENTSPLY SIRONA by 0.5% in the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after buying an additional 915 shares in the last quarter. Finally, Gabelli Funds LLC lifted its holdings in DENTSPLY SIRONA by 1.0% in the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier's stock worth $1,464,000 after buying an additional 1,000 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded up $0.04 during mid-day trading on Tuesday, reaching $16.11. 2,172,648 shares of the company's stock were exchanged, compared to its average volume of 2,577,223. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. The company has a 50-day simple moving average of $16.03 and a two-hundred day simple moving average of $16.16. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $27.95. The company has a market cap of $3.21 billion, a price-to-earnings ratio of -3.55, a PEG ratio of 1.15 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. During the same period last year, the company posted $0.42 EPS. The company's revenue was down 7.8% on a year-over-year basis. On average, sell-side analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.97%. DENTSPLY SIRONA's payout ratio is -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.